The U.S. surgical sutures market was valued at approximately USD 1.89 billion in 2025 and is anticipated to grow to USD 2.21 billion by 2030, registering a compound annual growth rate (CAGR) of 3.18% between 2025 and 2030. Growth is driven by increasing surgical procedures, including both elective and emergency surgeries, alongside expanding adoption of minimally invasive techniques.
An aging population with chronic diseases such as diabetes and cardiovascular conditions heightens demand for effective wound closure solutions. Surgical advancements and a rise in ambulatory surgery centers (ASCs) propel the need for efficient suturing products.
Technological innovation leads to products like absorbable antimicrobial sutures, improving surgical outcomes and expediting healing. For instance, DemeTECH Corporation offers a diverse portfolio of high-performance absorbable sutures tailored for specific clinical needs.
Regulatory oversight by the U.S. Food and Drug Administration (FDA) ensures sutures meet safety and efficacy standards, influencing product development and market access.
Absorbable sutures dominate due to their biodegradability and effectiveness in temporary wound support, eliminating the need for suture removal and minimizing complications.
The non-absorbable segment is also growing substantially, driven by need for permanent tissue support in cardiovascular, orthopedic, and ophthalmic surgeries.
Multifilament sutures lead in revenue share because of their ease of handling, superior knot security, and suitability for complex soft tissue closure.
Monofilament sutures are growing fastest due to benefits like reduced infection risk and minimal tissue trauma, favored in critical surgeries like cardiovascular and plastic surgery.
General surgery accounts for the largest market share, encompassing gastrointestinal surgery, hernia repair, and other high-volume procedures requiring effective suturing.
The cardiovascular segment is expected to register fastest growth, fueled by increasing cardiac surgeries and demand for sutures with enhanced tensile strength and biocompatibility.
| Report Attribute | Details |
|---|---|
| Market Size (2025) | USD 1,890.2 million |
| Revenue Forecast (2030) | USD 2,210.7 million |
| CAGR (2025-2030) | 3.18% |
| Base Year | 2024 |
| Historical Data | 2021–2023 |
| Forecast Period | 2025–2030 |
This report offers detailed forecasts and insights segmented by:
How large is the U.S. surgical sutures market?
The market was estimated at USD 1.83 billion in 2024.
What is the expected growth rate?
The market is projected to grow at a CAGR of 3.18% from 2025 to 2030.
Which segment holds the largest share?
Absorbable sutures lead due to their biodegradability and convenience.
Who are the major players?
Medtronic, Ethicon, Smith & Nephew, B. Braun, Teleflex, Dynarex, and DemeTECH are key participants.
